A Deep Learning–Based Decision Support Tool for Precision Risk Assessment of Breast Cancer

Abstract

PURPOSE The Breast Imaging Reporting and Data System (BI-RADS) lexicon was developed to standardize mammographic reporting to assess cancer risk and facilitate the decision to biopsy. Because of substantial interobserver variability in the application of the BI-RADS lexicon, the decision to biopsy varies greatly and results in overdiagnosis and excessive biopsies. The false-positive rate from mammograms is estimated to be 7% to approximately 10% overall, but within the BI-RADS 4 category, it is greater than 70%. Therefore, we developed the Breast Cancer Risk Calculator (BRISK) to target a well-characterized and specific patient subgroup (BI-RADS 4) rather than a broad heterogeneous group in assessing breast cancer risk. METHODS BRISK provides a novel precise risk assessment model to reduce overdiagnosis and unnecessary biopsies. It was developed by applying natural language processing and deep learning methods on 5,147 patient records archived in the Houston Methodist systemwide data warehouse from 2006 to May 2015, including imaging and pathology reports, mammographic images, and patient demographics. Key characteristics for BI-RADS 4 patients were collected and computed to output an index measure for biopsy recommendation that is clinically relevant and informative and improves upon the traditional BI-RADS 4 scores. RESULTS For the validation set, we assessed data from 1,247 BI-RADS 4 patients, including mammographic images and medical reports. The BRISK model sensitivity to predict malignancy was 100%, whereas the specificity was 74%. The total accuracy of our implemented model in BRISK was 81%. Overall area under the curve was 0.93. CONCLUSION BRISK for abnormal mammogram uses integrative artificial intelligence technology and has demonstrated high sensitivity in the prediction of malignancy. Prospective evaluation is under way and can lead to improvement in patient-physician engagement in making informed decisions with regard to biopsy.

An Artificial Intelligence-based Multimodality-Integration for Precise Prediction of Prostate Cancer Lymph Node Metastasis: A Retrospective Two-center Study

“…Additionally, the two new imaging hallmarks, were superior to most of those clinical factors in the weighted ensemble model, suggesting their incremental role on PCa risk assessment. Our ndings are consistent with those of previous studies, which used the similar computational approaches for breast cancer assessment 33,34 .…”

Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer

“…This data mining approach might be helpful and inspiring to solve similar medical problems. Our findings are consistent with those of previous studies, which used similar computational approaches for breast cancer assessment [39,40]. Additionally, we made a head-to-head comparison of PLNM-Risk with the MSKCC and Briganti nomograms.…”

A comparative efficacy study of diagnostic digital breast tomosynthesis and digital mammography in BI-RADS 4 breast cancer diagnosis

“…Our more recent study comparing 2D digital mammography with mostly initial DBT (only 0.59% DM + DBT) suggests that breast cancer evaluation with DBT may not have much comparative advantage over DM in clinical practice when it comes to detecting cancers or improving the PPV3 for BI-RADS 4-assessed lesions. DBT does not reduce unnecessary biopsies associated with BI-RADS 4 and brings to the fore the need for tools that could help to mitigate the problem of unnecessary biopsies [50].…”